| 1 |
Dos Santos Rodrigues B, Leroy K, Mihajlovic M, De Boever S, Vanbellingen S, Cogliati B, Aerts JL, Vinken M. Evaluation of functional candidate biomarkers of non-genotoxic hepatocarcinogenicity in human liver spheroid co-cultures. Arch Toxicol 2023. [PMID: 36941454 DOI: 10.1007/s00204-023-03486-4] [Reference Citation Analysis]
|
| 2 |
De Siervi S, Turato C. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer. Int J Mol Sci 2023;24. [PMID: 36901961 DOI: 10.3390/ijms24054529] [Reference Citation Analysis]
|
| 3 |
Gronert A, Zierau O, Thieme D, Keiler AM. Effect of HepG2 cell 3D cultivation on the metabolism of the anabolic androgenic steroid metandienone. Drug Test Anal 2023. [PMID: 36772854 DOI: 10.1002/dta.3455] [Reference Citation Analysis]
|
| 4 |
Trampuž SR, van Riet S, Nordling Å, Ingelman-Sundberg M. The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids. Cells 2023;12. [PMID: 36672237 DOI: 10.3390/cells12020302] [Reference Citation Analysis]
|
| 5 |
Yun C, Kim SH, Jung YS. Current Research Trends in the Application of In Vitro Three-Dimensional Models of Liver Cells. Pharmaceutics 2022;15. [PMID: 36678683 DOI: 10.3390/pharmaceutics15010054] [Reference Citation Analysis]
|
| 6 |
Kowalczyk K, Roszak J, Sobańska Z, Stępnik M. Review of mechanisms of genotoxic action of dibenzo[def,p]chrysene (formerly dibenzo[a,l]pyrene). Toxin Reviews. [DOI: 10.1080/15569543.2022.2124419] [Reference Citation Analysis]
|
| 7 |
Alves RF, Rocha E, Madureira TV. Fish hepatocyte spheroids - A powerful (though underexplored) alternative in vitro model to study hepatotoxicity. Comp Biochem Physiol C Toxicol Pharmacol 2022;262:109470. [PMID: 36122680 DOI: 10.1016/j.cbpc.2022.109470] [Reference Citation Analysis]
|
| 8 |
Hurrell T, Naidoo J, Scholefield J. Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance. Front Genet 2022;13:864725. [DOI: 10.3389/fgene.2022.864725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Youhanna S, Kemas AM, Preiss L, Zhou Y, Shen JX, Cakal SD, Paqualini FS, Goparaju SK, Shafagh RZ, Lind JU, Sellgren CM, Lauschke VM. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives. Pharmacol Rev 2022;74:141-206. [PMID: 35017176 DOI: 10.1124/pharmrev.120.000238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Pottegård A, Stage TB. Translational pharmacology: Closing the mechanistic gap. Basic Clin Pharmacol Toxicol 2022;130 Suppl 1:3-4. [PMID: 34821053 DOI: 10.1111/bcpt.13693] [Reference Citation Analysis]
|
| 11 |
Schofield CA, Walker TM, Taylor MA, Patel M, Vlachou DF, Macina JM, Vidgeon-Hart MP, Williams A, McGill PJ, Newman CF, Sakatis MZ. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury. Chem Res Toxicol 2021. [PMID: 34797640 DOI: 10.1021/acs.chemrestox.1c00227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Klaas M, Möll K, Mäemets-Allas K, Loog M, Järvekülg M, Jaks V. Long-term maintenance of functional primary human hepatocytes in 3D gelatin matrices produced by solution blow spinning. Sci Rep 2021;11:20165. [PMID: 34635750 DOI: 10.1038/s41598-021-99659-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Utoh R, Enomoto S, Yamada M, Yamanaka K, Yajima Y, Furusawa K, Seki M. Polyanion-induced, microfluidic engineering of fragmented collagen microfibers for reconstituting extracellular environments of 3D hepatocyte culture. Mater Sci Eng C Mater Biol Appl 2021;129:112417. [PMID: 34579926 DOI: 10.1016/j.msec.2021.112417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
